Investigational Site Number :2500004
Bron 69677
0 studies enrolling now · 3 studies all time
What they study most
Glycogen Storage Disease Type II;Pompe's Disease, Hemophilia A
Studies at this site
- Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A — Running, not enrolling
- Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A — Completed
- Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease — Completed